|
Published by: Kalorama Information
Published: Feb. 1, 2000 - 229 Pages Special Offer: Now 35%
off original sale price of $3250
Table of Contents
Chapter One: Executive Summary
- Introduction
- Scope And Methodology
- Size And Growth Of The Market
- Trends Affecting The Market
- Industry Structure And Leading Competitors
- The Consumer
Chapter Two: Introduction To Vaccines
- A Brief History: The Development Of Vaccines
- The Immune Response
- Mechanism Of Action
- Types Of Vaccines
- Live Attenuated Vaccines
- Killed Whole Vaccines
- Purified Component Vaccines
- Genetically Engineered Vaccines
- A New Technology: Nucleic Acid Vaccines
- How DNA Vaccines Differ From Recombinant DNA Vaccines
- Construction Of A DNA Vaccine
- Mechanism Of Action Of DNA Vaccines
- Administration Of DNA Vaccines
- Advantages Of DNA Vaccines
- Antibodies Against The Natural Forms Of Viral Proteins
- Raising Of Cytolytic T-Cell Responses
- Long-Lived Responses
- Facilitation Of Combination Vaccines
- Generic Production And Validation
- Stability
- Library Screening
- Manipulation Of The Vaccine Response
- Limitations Of DNA Vaccines Compared With Traditional Vaccines
- Potential Problems With DNA Vaccines
- DNA Vaccines As A Therapeutic Modality
- Adjuvants
- New Vaccine Product Introductions In 1997, 1998, And 1999
- Diphtheria, Tetanus, And Pertussis
- Lyme Disease
- Rabies
- Rotaviral Gastroenteritis
Chapter Three: Pediatric Preventive Vaccines
- Overview
- Childhood Immunization Rates
- Federal Immunization Programs
- Recommended Childhood Immunization Schedule
- Pediatric Vaccine Products
- BCG Vaccines
- Diphtheria, Tetanus, And Pertussis Vaccines
- Diphtheria
- Pertussis
- Tetanus
- Hemophilus Influenzae Type B Vaccines
- Hepatitis Vaccines
- Hepatitis A
- Hepatitis B
- Measles, Mumps, And Rubella Vaccines
- Measles
- Mumps
- Rubella
- Polio Vaccines
- Rotavirus Vaccines
- Varicella Vaccines
- Cost Of Pediatric Vaccines
- Pediatric Vaccines In Development
- Establishing Priorities In Vaccine Development
- Combination Vaccines
- Malaria Vaccines
- Meningococcus A, B, And C Vaccines
- Parainfluenza Virus Type 3 Vaccines
- Pneumococcal Disease Vaccines
- Respiratory Syncytial Virus Vaccines
- The U.S. Market For Pediatric Vaccines
- Total Market Size And Forecast
- DTP And DTAP Vaccines
- Market Size And Forecast
- Leading Products And Competitors
- Hemophilus Influenzae Type B Vaccines
- Market Size And Forecast
- Leading Products And Competitors
- Hepatitis Vaccines
- Market Size And Forecast
- Leading Products And Competitors
- Measles-Mumps-Rubella Vaccines
- Market Size And Forecast
- Leading Products And Competitors
- Poliovirus Vaccines
- Market Size And Forecast
- Leading Products And Competitors
- Varicella Vaccine
- Market Size And Forecast
- Leading Products And Competitors
- Competitor Analysis
- Market Analysis
Chapter Four: Adult Preventive Vaccines
- Overview
- Adult Immunization Rates
- Recommendations For Adult Immunization
- Recommendations For International Travelers
- Adult Vaccine Products
- BCG Vaccines
- Cholera Vaccines
- Hepatitis Vaccines
- Hepatitis A Vaccines
- Hepatitis B Vaccines
- Influenza Vaccines
- Japanese Encephalitis Vaccines
- Lyme Disease Vaccines
- Pneumococcal Disease Vaccines
- Rabies Vaccines
- Tetanus-Diphtheria Vaccines
- Typhoid Vaccines
- Yellow Fever Vaccines
- Adult Vaccines In Development
- Establishing Priorities In Vaccine Development
- Cholera Vaccines
- Dengue And Japanese Encephalitis Vaccines
- Epstein-Barr Virus Vaccines
- Group B Streptococcus Vaccines
- Helicobacter Pylori Vaccines
- Hepatitis Vaccines
- Hepatitis C
- Hepatitis D
- Hepatitis E
- Herpes virus Vaccines
- Influenza Vaccines
- Shigella Vaccine
- Traveler's Diarrhea Vaccines
- The U.S. Market For Adult Preventive Vaccines
- Total Market Size And Forecast
- Hepatitis A Vaccines
- Market Size And Forecast
- Leading Products And Competitors
- Hepatitis B Vaccines
- Market Size And Forecast
- Leading Products And Competitors
- Influenza Vaccines
- Market Size And Forecast
- Leading Products And Competitors
- Lyme Disease Vaccine
- Market Size And Forecast
- Leading Products And Competitors
- Pneumococcal Vaccines
- Market Size And Forecast
- Leading Products And Competitors
- Rabies Vaccines
- Market Size And Forecast
- Leading Products And Competitors
- Tetanus, Tetanus-Diphtheria, And Other Vaccine Products
- Market Size And Forecast
- Leading Products And Competitors
- Competitor Analysis
- Market Analysis
Chapter Five: Therapeutic Vaccines
- Overview
- Aids Vaccines
- Aids Statistics
- The Epidemic
- The Human Immunodeficiency Virus
- Aids Vaccines In Development
- Gp120 Vaccines
- Recombinant Vector Vaccines
- DNA Vaccines
- Peptide Vaccines
- Virus-like Particle Vaccines
- Live Attenuated Vaccines
- Whole Killed Vaccines
- The Future Of HIV Vaccine Development
- Cancer Vaccines
- Introduction
- Cancer Statistics
- Colon Cancer
- Melanoma
- Lung Cancer
- Prostate Cancer
- Current Methods Of Treating Cancer
- Cancer Vaccines: A New Modality Of Care
- Antigens: Their Role In Cancer Vaccines
- Vaccine Development Strategies
- Cancer Vaccines In Development
Chapter Six: Issues And Trends
- Introduction
- Vaccine Safety
- Pre-Licensure Evaluation
- Post-Licensure Surveillance
- Vaccine Adverse Event Reporting System
- The Vaccine Safety Datalink Project
- The Vaccine Injury Compensation Program
- Thimerosal In Vaccines
- Overview
- Joint Statement Released By The American Academy Of Pediatrics And The United
- States Public Health Service
- Key Actions Being Taken To Eliminate Thimerosal From Vaccines
- Vaccines And Bioterrorism
- Combination Vaccines
- Overview
- Advantages Of Combination Vaccines
- Disadvantages Of Combination Vaccines
- Innovations In Vaccine Delivery Systems
- Edible Vaccines
- Mucosal Delivery
- Intranasal Vaccine Delivery
- Needleless Injector Devices
- Oral Vaccines
- Vaccine Patches
Chapter Seven: Market Summary
- Trends Driving The Vaccines Market
- Market Size And Forecast
- Pediatric Vaccines
- Adult Vaccines
Chapter Eight: Competitor Profiles
- Introduction
- Aviron Corporation
- History And Lines Of Business
- Financial Information
- Vaccines
- Research And Development
- Corporate Strategies
- Biogen, Inc.
- History And Lines Of Business
- Financial Information
- Vaccines
- Research And Development
- Corporate Strategies
- Biomira Inc.
- History And Lines Of Business
- Financial Information
- Vaccines
- Research And Development
- Corporate Strategies
- Chiron Corporation
- History And Lines Of Business
- Financial Information
- Vaccines
- Research And Development
- Corporate Strategies
- Merck & Company, Inc.
- History And Lines Of Business
- Financial Information
- Vaccines
- Research And Development
- Corporate Strategies
- North American Vaccine Inc.
- History And Lines Of Business
- Financial Information
- Vaccines
- Research And Development
- Corporate Strategies
- Pasteur Mérieux Connaught USA
- History And Lines Of Business
- Financial Information
- Vaccines
- Research And Development
- Corporate Strategies
- Smithkline Beecham PLC
- History And Lines Of Business
- Financial Information
- Vaccines
- Research And Development
- Corporate Strategies
- Vical Inc.
- History And Lines Of Business
- Financial Information
- Vaccines
- Research And Development
- Corporate Strategies
- Wyeth-Ayerst Laboratories
- History And Lines Of Business
- Financial Information
- Vaccines
- Research And Development
- Corporate Strategies
- Appendix A: Vaccine Products
- Appendix B: Company Names And Addresses
AbstractThis report details the most recent product approvals and
developments in the vaccines market. Find out the latest in the
development of single-dose and combined vaccines, and DNA
vaccines. The report analyzes the trends shaping the future of the
vaccines industry with an understandable, comprehensive
overview of the technological advances in bioengineering and
recombinant DNA research. Included are forecast sales for vaccine
products to the year 2004, and an assessment of which pharmaceutical
companies are leading the vaccine industry and which companies are
likely to be future leaders. The report also details the life-saving potential of therapeutic vaccines for treating cancer,
AIDS, and autoimmune diseases.
Get Full Details About This Report >>
|
